Francis Lynn
-
New study makes key findings in potential advancement of diabetes cure
Stem cell-based therapies are some of the most promising approaches for treating type 1 diabetes (T1D), an autoimmune disease that destroys insulin-producing beta cells. Beta cells sense glucose (sugar from foods) and release insulin into the blood to regulate energy delivery to the cells all over the body. Stem cells can be transformed into replacements…
-
Reimagining Patient Care: Q&A with Dr. Stuart Turvey, Precision Health Lead
In 2016, BC Children’s Hospital Research Institute set out to become one of the top pediatric research institutes in North America. To achieve this, BCCHR set out their strategic initiatives to create innovative solutions to some of the biggest health problems.
-
New research funding to accelerate stem cell-based therapies for type 1 diabetes
A new national research team led by BC Children’s Hospital’s Dr. Francis Lynn was one of two groups awarded a total of $6 million in funding from the Government of Canada and JDRF Canada to accelerate the development of stem cell based therapies for type 1 diabetes (T1D).
For Media
Every day, our researchers are working towards breakthroughs to transform the lives of kids in British Columbia and around the world. Learn about the latest innovations and advancements in child health.
for media